DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2DR REDDYS LABS SA
02 3STRIDES PHARMA
03 4STRIDES PHARMA INTL
04 15GRANULES
05 3ABLE
06 7ACCORD HLTHCARE
07 20ACTAVIS ELIZABETH
08 6ACTAVIS LABS FL INC
09 9ALKEM LABS LTD
10 7ALVOGEN
11 2AMNEAL PHARMS
12 3ANDA REPOSITORY
13 7ANI PHARMS
14 13ASCENT PHARMS INC
15 17AUROLIFE PHARMA LLC
16 2AVANTHI INC
17 14AZURITY
18 9BARR
19 6BARR LABS INC
20 2BIONPHARMA
21 5CEDIPROF INC
22 6COREPHARMA
23 13ELITE LABS INC
24 11EPIC PHARMA LLC
25 1FERNDALE LABS
26 2GLAXOSMITHKLINE
27 2GLENMARK PHARMS LTD
28 1HALSEY
29 6IMPAX LABS
30 3IMPAX LABS INC
31 5LANNETT
32 13LANNETT CO INC
33 6LUPIN
34 1MAST MM
35 6NEOS THERAPS
36 1NEOS THERAPS INC
37 13NESHER PHARMS
38 2NOVAST LABS
39 2NOVEL LABS INC
40 4NOVEN PHARMS INC
41 9NUVO PHARM
42 6ORYZA
43 6PH HEALTH
44 10PHARMOBEDIENT
45 1PRASCO
46 2PRINSTON INC
47 1PUREPAC PHARM
48 15RHODES PHARMS
49 2SANALUZ
50 5SANDOZ
51 2SENORES PHARMS
52 2SHIRE
53 2SMITH KLINE & FRENCH
54 24SPECGX LLC
55 6SUN PHARM INDS INC
56 13SUN PHARM INDUSTRIES
57 10TAKEDA PHARMS USA
58 17TEVA
59 4TEVA PHARMS
60 4TEVA PHARMS USA
61 7TEVA WOMENS
62 8TRIS PHARMA INC
63 3UCB INC
64 2VITARINE
65 7WINDER LABS LLC
66 7ZYDUS PHARMS
01 154CAPSULE, EXTENDED RELEASE;ORAL
02 5CAPSULE;ORAL
03 1ELIXIR;ORAL
04 2SOLUTION;ORAL
05 2SUSPENSION, EXTENDED RELEASE;ORAL
06 4SYSTEM;TRANSDERMAL
07 4TABLET, EXTENDED RELEASE;ORAL
08 12TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
09 5TABLET, ORALLY DISINTEGRATING;ORAL
10 238TABLET;ORAL
11 2Tablet; Oral
01 136DISCN
02 285RX
03 8Blank
01 1ADDERALL 10
02 1ADDERALL 12.5
03 1ADDERALL 15
04 1ADDERALL 20
05 1ADDERALL 30
06 1ADDERALL 5
07 1ADDERALL 7.5
08 1ADDERALL XR 10
09 1ADDERALL XR 15
10 1ADDERALL XR 20
11 1ADDERALL XR 25
12 1ADDERALL XR 30
13 1ADDERALL XR 5
14 1ADZENYS ER
15 6ADZENYS XR-ODT
16 6AMPHETAMINE
17 32AMPHETAMINE SULFATE
18 2BENZEDRINE
19 1BIPHETAMINE 12.5
20 1BIPHETAMINE 20
21 1BIPHETAMINE 7.5
22 8DELCOBESE
23 3DEXAMPEX
24 2DEXEDRINE
25 3DEXEDRINE SPANSULE
26 244DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
27 6DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE
28 6DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAM
29 71DEXTROAMPHETAMINE SULFATE
30 2DEXTROSTAT
31 1DYANAVEL XR
32 1DYANAVEL XR 10
33 1DYANAVEL XR 15
34 1DYANAVEL XR 20
35 1DYANAVEL XR 5
36 2EVEKEO
37 5EVEKEO ODT
38 1FERNDEX
39 4MYDAYIS
40 4XELSTRYM
01 375No
02 46Yes
03 8Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : AMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 2020-07-14
Application Number : 213898
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 1999-05-13
Application Number : 40299
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code : AA
Brand Name : AMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 2019-08-05
Application Number : 212619
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : AMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Approval Date : 2020-07-14
Application Number : 213898
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 15MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code : AB
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code : AB
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code : AB
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 15MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
